Raloxifene: is it really effective on mood changes in postmenopausal osteopenic women?

References

• Harlow BL, Cohen LS, Otto MW, Spiegelman D, Cramer DW. Prevalence and predictors of depressive symptoms in older premenopausal women: the Harvard study of moods and cycles. Arch Gen Psychiatry 1999;56:418–424.
   PubMed Web of Science ®Google Scholar
• Inan I, Kelekci S, Yilmaz B. Psychological effects of tibolone and sequential estrogenprogestogen therapy in perimenopausal women. Gynecol Endocrinol 2005;20:64–67.
   Web of Science ®Google Scholar
• Huttner RP, Shepherd JE. Gonadal steroids, selective serotonin reuptake inhibitors, and mood disorders in women. Med Clin Nort Am 2003;87:1065–1076.
   PubMed Web of Science ®Google Scholar
• Yen SSC, Jaffe RB. Reproductive endocrinology. Philadelpia: W.B. Sonders; 1991.
   Google Scholar
• Sherwin BB. Hormones, mood and cognitive functioning in postmenopausal women. Obstet Gynaecol 1996;87:20–26.
   PubMed Web of Science ®Google Scholar
• Baksu A, Ayas B, Citak S, Kalan A, Baksu B, Goker N. Efficacy of tibolone and transdermal estrogen therapy on psychological symptoms in women following surgical menopause. Int J Gynaecol Obstet 2005;91:58–62.
   Google Scholar
• Rasgon NL, Altshuler LL, Fairbanks LA, Dunkin JJ, Davtyan S, Elman S, Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry 2002;63(Suppl. 7):45–48.
   PubMedGoogle Scholar
• Khovidhunkit W, Shoback DM. Clinical effects of raloxifene hydrochloride in women. Ann Intern Med 1999;130:431–439.
   PubMed Web of Science ®Google Scholar
• Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641–1647.
   PubMed Web of Science ®Google Scholar
• Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 1999;282:637–645.
   PubMed Web of Science ®Google Scholar
• Cyr M, Landry M, Di Paolo T. Modulation by estrogenreceptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacology 2000;23:69–78.
   PubMedGoogle Scholar
• Nickelsen T, Lufkin EG, Riggs BL, Cox DA, Crook III TH. Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocrinology 1999;24:115–128.
   PubMed Web of Science ®Google Scholar
• Strickler R, Stovall DW, Merritt D, Shen W, Wong M, Silfen SL. Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial. Obstet Gynecol 2000;96:359–365.
   PubMed Web of Science ®Google Scholar
• Kupperman HS, Blat MHG, Wiesbader H, Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol 1953;13:688–703.
   PubMed Web of Science ®Google Scholar
• Bekiroglu N, Gurbuz A, Konyalioglu R, Ayas S, Akif A, Eren S. The comparison of menopause rating scale (MRS), Kupperman index (KI) and Nottingham health profile (NHP) by means of reliability measures and responsiveness indexes among menopausal women. Zeynep Kamil Tıp Bülteni 2008;39:11–16.
   Google Scholar
• Bech P, Hamilton M, Zung WWK. The Bech, Hamilton and Zung scales for mood disorders: screening and listening: A twenty years update with reference to DSM-IV and ICD-10. 2nd ed. Berlin: Springer-Verlag; 1996.
   Google Scholar
• Akdemir A, Orsel S, Dag I, Turkcapar H, Iscan N, Ozbay H. The validity, reliability and clinical use of Hamilton depression rating scale. J Psychiatr Psychol Psychopharmacol 1996;4: 251–259.
   Google Scholar
• Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893–897.
   PubMed Web of Science ®Google Scholar
• Ulusoy M, Sahin N, Erkman H. Turkish Version of the Beck Anxiety Inventory: psychometric properties. J Cognit Psychotherapy: Int Quaterly 1988;12:28–35.
   Google Scholar
• Jarkova NB, Martenyi F, Masanauskaite D, Walls EL, Smetnik VP, Pavo I. Mood effect of raloxifene in postmenopausal women. Maturitas 2002;42:71–75.
   PubMed Web of Science ®Google Scholar
• Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641–1647.
   PubMed Web of Science ®Google Scholar
• Walsh BW, Kuller LH, Wild RA, Paul S, Farmer M, Lawrence JB, Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 1998;279:1445–1451.
   PubMed Web of Science ®Google Scholar